liothyronine sodium
- Product NDC
- 62756-590
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liothyronine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA091382
- Marketing category
- ANDA
- Substance
- LIOTHYRONINE SODIUM
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 62756-590-01 | 90 TABLET in 1 BOTTLE (62756-590-01) | 2023-06-26 | | No | Historical |
| 62756-590-08 | 100 TABLET in 1 BOTTLE (62756-590-08) | 2019-11-28 | | No | Historical |
| 62756-590-18 | 1000 TABLET in 1 BOTTLE (62756-590-18) | 2019-11-28 | | No | Historical |
| 62756-590-83 | 30 TABLET in 1 BOTTLE (62756-590-83) | 2019-11-28 | | No | Historical |
| 62756-590-88 | 100 TABLET in 1 BOTTLE (62756-590-88) | 2019-11-28 | | No | Historical |